Company / Operating Cash Flow per Share
Cyclerion Therapeutics, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.30
FY2025
5-year range
-$18.66 / -$0.94
FY2021-FY2025
Trend
+84.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-18.66 to $-1.30 over the past 2 years.
Based on SEC 10-K filings.
-1.30 in FY2025.
Improved from $-18.66 to $-1.30 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 84.8% year-over-year.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.30 | +84.8% |
| FY2024 | -$8.59 | +54.0% |
| FY2023 | -$18.66 | -1895.0% |
| FY2022 | -$0.94 | +60.8% |
| FY2021 | -$2.38 | +35.6% |
| FY2020 | -$3.70 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026